Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06355791

Post-Market Clinical Study of Functional Motion Outcomes in Subjects Treated With the Minuteman Device

Led by Spinal Simplicity LLC · Updated on 2025-10-03

150

Participants Needed

6

Research Sites

339 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This is a prospective, multi-center open-label single arm post-market study where the purpose is to evaluate the effectiveness and safety of the market approved Spinal Simplicity Minuteman G5 MIS Fusion Plate and bone graft material in patients with degenerative conditions of the lumbar spine resulting in chronic low back pain with lower extremity symptoms and concurrent neurogenic claudication. The indication for the device under study is degenerative conditions of the lumbar spine resulting in back pain with lower extremity symptoms and neurogenic claudication.

CONDITIONS

Official Title

Post-Market Clinical Study of Functional Motion Outcomes in Subjects Treated With the Minuteman Device

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Be a candidate for the Spinal Simplicity Minuteman G5 Fusion Plate device as per its labeled indication
  • Be willing and able to give written consent to participate voluntarily
  • Be able to understand and complete written questionnaires and informed consent
  • Be 18 years of age or older at enrollment
  • Diagnosed with degenerative lumbar spine conditions causing chronic low back pain with lower extremity symptoms and neurogenic claudication
  • Have received at least 3 months of non-operative or conservative treatment without significant benefit
  • Be willing and able to follow all study procedures and visits
  • Be on a stable pain medication regimen for at least 30 days before enrollment
  • Disclose any unresolved issues of secondary gain, such as ongoing injury claims or worker's compensation, though these will not exclude participation
Not Eligible

You will not qualify if you...

  • Previous spinal surgery at the intervention level (except MILD procedure)
  • Physically unable to perform gait or balance tests
  • Current systemic or local infection increasing surgery risk
  • Use of medications that reduce bone quality or tissue healing
  • Grade II to V spondylolisthesis
  • Significant scoliosis with Cobb angle over 10 degrees
  • Unremitting back pain when bending forward
  • Active systemic disease affecting health
  • Participation in another clinical drug or device study that may affect results
  • Vertebral osteoporosis or history of vertebral fracture
  • Pregnant, lactating, or planning pregnancy through 3 months post-op (with required birth control if applicable)
  • Malformation or dysplasia of the spinous process
  • Severe osteoporosis with T score less than -2.5 SD

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 6 locations

1

Vista Clinical Research

Newnan, Georgia, United States, 30265

Actively Recruiting

2

Comprehensive Pain & Spine Specialists

Indianapolis, Indiana, United States, 46250

Actively Recruiting

3

University of Kansas Medical Center

Kansas City, Kansas, United States, 66160

Not Yet Recruiting

4

Nura Precision Pain Management

Edina, Minnesota, United States, 55435

Actively Recruiting

5

Pacific Sports & Spine

Eugene, Oregon, United States, 97404

Actively Recruiting

6

Spine & Nerve Center of the Virginias

Charleston, West Virginia, United States, 25301

Actively Recruiting

Loading map...

Research Team

E

Echo Cundiff

CONTACT

A

Adam Rogers

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here